Omicron-specific Sinopharm COVID-19 vaccine candidates cleared for clinical trial - Rappler

The two vaccine candidates contain inactivated or "killed" Omicron virus and similar to the two Sinopharm vaccines in use in China

BEIJING, China Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant were approved for clinical trials as boosters in Hong Kong, the S… [+1116 chars]

full article...